Lymphoma Hub
@lymphomahub
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) linktr.ee/Lymphoma #lymsm
ID: 1582593798
http://www.lymphomahub.com 10-07-2013 08:56:22
10,10K Tweet
9,9K Followers
2,2K Following
CONGRESS | #SOHO2024 William Wierda, MD Anderson Cancer Center, presents post hoc exploratory analysis results of the phase I/II TRANSCEND CLL 004 study evaluating characteristics associated with response to liso-cel in pts with R/R CLL/SLL (n=87). OR and CR rates did not correlate with